Screener
Summit Therapeutics SMMT Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Summit Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Summit Therapeutics’s 10-K, filed February 23, 2026. Open the filing →
- Filed
- Feb 23, 2026, 4:10 PM EST
- Fiscal year
- FY2025
- Accession
- 0001599298-26-000015
FAQ
- What is Summit Therapeutics's asset turnover?
- Summit Therapeutics (SMMT) reported asset turnover of 0× in Q4 2023.
- How has Summit Therapeutics's asset turnover changed year-over-year?
- Summit Therapeutics's asset turnover decreased by 100.0% year-over-year, from 0× to 0×.
- What is the long-term trend for Summit Therapeutics's asset turnover?
- Over 3 years (2020 to 2023), Summit Therapeutics's asset turnover has grown at a -100.0% compound annual growth rate (CAGR), from 0× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Summit Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude